Co-Diagnostics
(NASDAQ) CODX
Co-Diagnostics Financials at a Glance
Market Cap
$26.30M
Revenue (TTM)
$718.17K
Net Income (TTM)
-$48.50M
EPS (TTM)
-$28.01
P/E Ratio
-0.26
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$7.58
Volume
356,762.123
Open
$8.06
Price
$7.58
Volume
356,762.123
Open
$8.06
Previous Close
$7.30
Daily Range
$6.64 - $11.85
52-Week Range
$1.26 - $1,395.00
Dividend
$0.00
Beta (Volatility)
1.06 (Average)
Price
$7.58
Volume
356,762.123
Open
$8.06
Previous Close
$7.30
Daily Range
$6.64 - $11.85
52-Week Range
$1.26 - $1,395.00
CODX News
Why Co-Diagnostics Is Soaring Today
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Co-Diagnostics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
115
CEO
Dwight Howard Egan
Website
co-dx.comHeadquarters
Salt Lake City, UT 84109, US
CODX Financials
Key Financial Metrics (TTM)
Gross Margin
9%
Operating Margin
-44%
Net Income Margin
-68%
Return on Equity
-152%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-3.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$26.30M
Shares Outstanding
3.60M
Volume
356.76K
Avg. Volume
7.06M
Financials (TTM)
Gross Profit
$400.11K
Operating Income
-$31.28M
EBITDA
-$30.18M
Operating Cash Flow
-$29.14M
Capital Expenditure
-$700.05K
Free Cash Flow
-$29.84M
Cash & ST Invst.
$11.88M
Total Debt
$1.24M
Co-Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$145.95K
+190.3%
Gross Profit
-$303.26K
-1157.1%
Gross Margin
-2.08%
N/A
Market Cap
$26.30M
N/A
Market Cap/Employee
$199.23K
N/A
Employees
132
N/A
Net Income
-$9.14M
-21.3%
EBITDA
-$8.95M
-8.2%
Quarterly Fundamentals
Net Cash
$6.20M
-68.3%
Accounts Receivable
$82.39K
-39.6%
Inventory
$846.12K
-21.9%
Long Term Debt
$1.17M
+14.0%
Short Term Debt
$857.64K
-5.0%
Return on Assets
-2.26%
N/A
Return on Invested Capital
-1.86%
N/A
Free Cash Flow
-$7.99M
+9.6%
Operating Cash Flow
-$7.85M
+10.3%